| 000 | 01745 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516164606.0 | ||
| 264 | 0 | _c20150109 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2013.07.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPišlar, Anja Hafner | |
| 245 | 0 | 0 |
_aCathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cJul 2014 |
||
| 300 |
_a121-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAminobutyrates _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCathepsin Z _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCathepsins _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCysteine Endopeptidases _xmetabolism |
| 650 | 0 | 4 |
_aCytochromes c _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aI-kappa B Kinase _xmetabolism |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 |
_aSuccinates _xpharmacology |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aZidar, Nace | |
| 700 | 1 | _aKikelj, Danijel | |
| 700 | 1 | _aKos, Janko | |
| 773 | 0 |
_tNeuropharmacology _gvol. 82 _gp. 121-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2013.07.040 _zAvailable from publisher's website |
| 999 |
_c23016428 _d23016428 |
||